Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pfizer Inc.

Expert Illustrations & Commentaries™: Roles and Rationales for BCMA-Directed Therapies in Multiple Myeloma

Release Date: December 23, 2021
Expiration Date: December 23, 2022

Activity Overview

This Expert Illustrations and CommentariesTM online activity is a video-based program in which 2 experts discuss emerging treatments in multiple myeloma (MM), namely B-cell directed maturation antigen (BCMA) therapy. In this activity, the faculty focus on treatments for both newly diagnosed (ND) and relapsed/refractory (RR) multiple myeloma. Their discussion is enriched with the addition of video animations to illustrate the mechanism of action of various BCMA therapies, including antibody-drug conjugates (ADC), bispecific T-cell engagers (BiTE), and chimeric antigen receptor (CAR) T-cell agents. This unique format is designed to help clinicians understand the mechanism of emerging agents to identify best practices in the treatment of MM and to improve outcomes for their patients with this disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Pfizer Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward medical oncologists/hematologists, and other oncology HCPs involved in the treatment of multiple myeloma. Advanced practitioners, nurses, pharmacists, and other healthcare professionals interested in multiple myeloma will be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the rationale for targeting BCMA in R/R MM and the mechanisms of action for therapeutic agents acting through BCMA
  • Assess pivotal trials’ results from studies that evaluated current and emerging BCMA-targeted agents evaluated for the treatment of patients with R/R MM
  • Implement strategies to promptly identify and mitigate toxicities associated with agents targeting BCMA in R/R MM

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies. 


Vivian Laquer, MD, FAAD
Noopur Raje, MD
Professor of Medicine
Program Director
Center for Multiple Myeloma
Massachusetts General Hospital
Boston, MA

Disclosures: Grant/Research Support: bluebird bio; Consultant: Celgene, Takeda, Amgen, Bristol Myers Squibb, Karyopharm Therapeutics

Clara C. Chan, MD, FRCSC, FACS, DABO
Cristina Gasparetto, MD
Professor of Medicine
Director, Multiple Myeloma Program
Duke Cancer Institute
Durham, NC

Disclosures: Consultant: AbbVie, GlaxoSmithKline, Karyopharm Therapeutics, Sanofi; Speaker’s Bureau: Bristol Myers Squibb, GlaxoSmithKline, Karyopharm Therapeutics, Oncopeptides, Inc., Sanofi

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By